Clinical Trial Update: Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating enhanced digital-chemosensory-based olfactory training for remote management of substance use disorders is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Cocaine Use Disorder
• Methamphetamine Dependence
• Opioid Use Disorder
• Substance Use Disorder

Drugs mentioned

• Enhanced digital-chemosensory-based olfactory training

Snippet

Sponsor: Evon Medics LLC | Conditions: Substance Use Disorders, Opioid Use Disorder | Phase 2 | Status: RECRUITING